Daniel V. Araujo

211 Professor Antonio Prudente Street
Sao Paulo, SP 01509900, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications

Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysis.

Circulating tumor DNA for predicting recurrence and mortality in patients with resected Melanoma: A systematic review and meta-analysis.

Journal: Cancer treatment reviews
Published: April 01, 2026

Role of Postoperative Radiation Therapy After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.

Role of Postoperative Radiation Therapy After Radical Cystectomy for Bladder Cancer: A Systematic Review and Meta-Analysis.

Journal: Advances in radiation oncology
Published: January 15, 2026

Low-Dose Abiraterone in Metastatic Castration-Resistant Prostate Cancer.

Low-Dose Abiraterone in Metastatic Castration-Resistant Prostate Cancer.

Journal: JCO global oncology
Published: September 03, 2025

Tebentafusp in Metastatic Uveal Melanoma: A Meta-analysis.

Tebentafusp in Metastatic Uveal Melanoma: A Meta-analysis.

Journal: Targeted oncology
Published: August 04, 2025

Analysis of control arms in oncology randomised trials in Brazil: a cross-sectional study.

Analysis of control arms in oncology randomised trials in Brazil: a cross-sectional study.

Journal: BMJ oncology
Published: March 11, 2025

Dabrafenib and trametinib vs anti-PD(L)1 for the adjuvant treatment of locally advanced BRAF-mutant melanoma: a systematic review and meta-analysis.

Dabrafenib and trametinib vs anti-PD(L)1 for the adjuvant treatment of locally advanced BRAF-mutant melanoma: a systematic review and meta-analysis.

Journal: The oncologist
Published: March 07, 2025

Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: a systematic review and meta-analysis.

Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: a systematic review and meta-analysis.

Journal: Breast cancer research and treatment
Published: February 23, 2025

Low-Dose Anti-PD(L)1 for the Treatment of Solid Malignancies.

Low-Dose Anti-PD(L)1 for the Treatment of Solid Malignancies.

Journal: JCO global oncology
Published: November 21, 2024

Role of consolidative surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC): Princess Margaret Cancer Centre experience.

Role of consolidative surgery after chemotherapy in recurrent/metastatic adrenal cortical cancer (ACC): Princess Margaret Cancer Centre experience.

Journal: BJC reports
Published: October 16, 2024

Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patients.

Bespoke ctDNA for longitudinal detection of molecular residual disease in high-risk melanoma patients.

Journal: ESMO open
Published: May 26, 2024

Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.

Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update.

Journal: Journal of cancer research and clinical oncology
Published: December 27, 2023

Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials.

Tumor-Naïve Circulating Tumor DNA as an Early Response Biomarker for Patients Treated With Immunotherapy in Early Phase Clinical Trials.

Journal: JCO precision oncology
Published: April 07, 2023
Showing 1-12 of 39

Last Updated: 09/26/2026